Sage Journals: Discover world-class research

Abstract

Treatment with interferon (IFN)-β1a has been associated with decreased disease activity in patients with multiple sclerosis (MS). In several biological systems, type I IFNs and retinoids have been demonstrated to have synergistic effects. In these studies, we measured blood and cerebrospinal fluid (CSF) retinol levels and naïve and memory T-helper cell subset percentages in samples from a group of patients with MS. We also examined retinol receptor expression in peripheral blood cells from MS patients with or without a history of prior treatment with IFN-β1a. The mean plasma retinol level for untreated relapsing-remitting (RR) MS patients was lower than for patients with noninflammatory neurological disease. Among IFN-β1a-treated RR patients, mean levels were slightly higher than for RR patients not on treatment. Lower plasma retinol levels among the MS patients studied were associated with higher CSF retinol index measurements - a measure that was calculated to correct for nonspecific leakage of retinol from blood into CSF. For the MS samples examined, there was a borderline statistically significant direct correlation between CSF retinol index measurements and CSF memory T-helper cell percentages. Examination of peripheral blood from untreated RR patients for retinoid receptor mRNA expression revealed the expression of the retinoic acid receptor (RAR)-α, RAR-γ, and retinoic X receptor (RXR)-α receptor subtypes. For RR patients on IFN-β1a therapy, expression of the same RAR subtypes was noted as well as expression of RXR-βand RXR-γ. These studies suggest an association between plasma retinol levels and clinical disease activity in patients with MS and that treatment with IFN-β1a may be associated with activation of specific retinoid receptor subtypes.

Keywords

interferon-β 1a multiple sclerosis RAR RXR retinol T-cell activation vitamin A

Get full access to this article

View all access options for this article.

References

Gambi D , Porrini AM , Giampietro A , Macor S. CD21+ (B2 antigen+) cell decrement and CD4+CD29+ (helper-inducer) cell increment suggest a activations of cell immune reactivity in multiple sclerosis . J Neuroimmunol 1991; 33: 97-102 .

Khoury SJ , Weiner HL , Hafler DA. Immunological mechanisms in multiple sclerosis. In Cook SD ed. Handbook of multiple sclerosis, Volume 2. New York: Marcel Dekker , 1990: 145-155.

Jacobs LD , Cookfair DL , Rudick RA , et al. Intramuscular inter-feron beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Group (MSCG) . Ann Neurol 1996; 39: 285-294 .

The IFNB Multiple Sclerosis Study Group . Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial . Neurology 1993; 43: 655-661 .

Cantorna MT , Nashold FE , Chun TY , Hayes CE. Vitamin A down-regulation of IFN-gamma synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway . J Immunol 1996; 156: 2674-2679 .

Cantorna MT , Nashold FE , Hayes CE. Vitamin A deficiency results in a priming environment conducive for Th1 cell development . Eur J Immunol 1995; 25: 1673-1679 .

Cantorna MT , Nashold FE , Hayes CE. In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function . J Immunol 1994; 152: 1515-1522 .

Carman JA , Hayes CE. Abnormal regulation of IFN-gamma secretion in vitamin A deficiency . J Immunol 1991; 147: 1247-1252 .

Chun TY , Carman JA , Hayes CE. Retinoid repletion of vitamin A-deficient mice restores IgG responses . J Nutr 1992; 122: 1062-1069 .

10.

Racke MK , Burnett D , Pak S-H , et al. Retinoid treatment of experimental allergic encephalomyelitis . J Immunol 1995; 154: 450-458 .

11.

Massacesi L , Castigli E , Vergeli M , et al. Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats . J Clin Invest 1991; 88: 1331-1337 .

12.

Massacesi L , Abbamondi AL , Giorgi C , et al. Suppression of experimental allergic encephalomyelitis by retinoic acid . J Neurol Sci 1987; 80: 55-64 .

13.

Qu ZX , Dayal A , Jensen MA , Arnason BG. All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis . Arch Neurol 1998; 55: 315-321 .

14.

Qu ZX , Pliskin N , Jensen MW , et al. Etretinate augments inter-feron beta-1b effects on suppressor cells in multiple sclerosis . Arch Neurol 2001; 58: 87-90 .

15.

Evans RM. The steroid and thyroid hormone receptor superfamily . Science 1988; 240: 889-895 .

16.

Heyman RA , Mangelsdorf DJ , Dyck JA , et al. 9-cis-Retinoic acid is a high affinity ligand for the retinoid X receptor . Cell 1992; 68: 397-406 .

17.

Egea PF , Rochel N , Birck C , et al. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR . J Mol Biol 2001; 307: 557-576 .

18.

Mangelsdorf DJ , Ong ES , Dyck JA , Evans RM. Nuclear receptor that identifies a novel retinoic acid-response pathway . Nature 1990; 345: 224-229 .

19.

Levin AA , Sturzenbecker LJ , Kazmer S , et al. 9-cis-Retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha . Nature 1992; 355: 359-361 .

20.

Mangelsdorf DJ , Umesono K , Evans RM. Retinoid receptors. In Sporn MB , Roberts AB , Goodman DS eds. The retinoids, Volume 2. New York: Raven Press , 1994: 319-350.

21.

Lomo J , Smeland EB , Ulven S , et al. RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis on B-lymphocytes . J Cell Physiol 1998; 175: 68-77 .

22.

Ballow M , Xiang S , Greenberg SJ , et al. Retinoic acid-induced modulation of IL-2 mRNA production and IL-2 receptor expression on T cells . Int Arch Allergy Immunol 1997; 113: 167-169 .

23.

Green HN , Mellanby E. Vitamin A as an anti-infective agent . BMJ 1928; 2: 691-696 .

24.

Bieri JG , Tolliver TJ , Catignani GL. Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography . Am J Clin Nutr 1979; 32: 2143-2149 .

25.

Ferrari N , Vidali G , Pfeffer U. Use of quantitative polymerase chain reaction to study retinoid receptor expression . Methods Enzymol 1997; 282: 48-64 .

26.

Mezes M , Bartosiewicz B. Investigations concerning vitamin A transport in rheumatic diseases . Clin Rheumatol 1982; 1: 190-193 .

27.

Mezes M , Bartosiewicz G , Nemeth J. Comparative investigations on vitamin A level of plasma in some rheumatic diseases . Clin Rheumatol 1986; 5: 221-224 .

28.

Honkanen V , Konttinen YT , Mussalo-Rauhamaa H. Vitamins A and E, retinol binding protein and zinc in rheumatoid arthritis . Clin Exp Rheumatol 1989; 7: 465-469 .

29.

Comstock GW , Burke AE , Hoffman SC , et al. Serum concentrations of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus . Ann Rheum Dis 1997; 56: 323-325 .

30.

Brinckerhoff CE , McMillan RM , Dayer JM , Harris ED Jr. Inhibition by retinoic acid of collagenase production in rheumatoid synovial cells . N Engl J Med 1980; 303: 432-436 .

31.

Brinckerhoff CE , Coffey JW , Sullivan AC. Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis-retinoic acid . Science 1983; 221: 756-758 .

32.

Furr HC , Barua AB , Olson JA. Analytical methods. In Sporn MB , Roberts AB , Goodman D-WS eds. The retinoids, second edition. New York: Raven Press , 1994: 179-210.

33.

Pilch SM. Analysis of vitamin A data from the health and nutrition examination surveys . J Nutr 1987; 117: 636-640 .

34.

Lewis CJ , McDowell MA , Sempos CT , et al. Relationship between age and serum vitamin A in children aged 4- 11 y . Am J Clin Nutr 1990; 52: 353-360 .

35.

Ravaglia G , Forti P , Maioli F , et al. Blood micronutrient and thyroid hormone concentrations in the oldest-old . J Clin Endocrinol Metab 2000; 85: 2260-2265 .

36.

Hallfrisch J , Muller DC , Singh VN. Vitamin A and E intakes and plasma concentrations of retinol, beta-carotene, and alpha-tocopherol in men and women of the Baltimore Longitudinal Study of Aging . Am J Clin Nutr 1994; 60: 176-182 .

37.

Crucian B , Dunne P , Friedman H , et al. Alterations in levels of CD28−/CD8 + suppressor cell precursor and CD45RO+/CD4+ memory T lymphocytes in the peripheral blood of multiple sclerosis patients . Clin Diagn Lab Immunol 1995; 2: 249-252 .

38.

Chofflon M , Weiner JL , Morinoto C , Hafler DA. Decrease of suppressor inducer (CD4 +2H4 +) T cells in multiple sclerosis cerebrospinal fluid . Ann Neurol 1989; 25: 494-497 .

39.

Szondy Z , Reichert U , Bernardon JM , et al. Induction of apoptosis by retinoids and retinoic acid receptor gamma-selective compounds in mouse thymocytes through a novel apoptosis pathway . Mol Pharmacol 1997; 51: 972-982 .

40.

Lippman SM , Lotan R , Schleuniger U. Retinoid-interferon therapy of solid tumors . Int J Cancer 1997; 70: 481-483 .

41.

Windbichler GH , Hensler E , Widschwendter M , et al. Increased radiosensitivity by a combination of 9-cis-retinoic acid and interferon-y in breast cancer cells . Gynecol Oncol 1996; 61: 387-394 .

42.

Moore DM , Kalvakolanu DV , Lippman SM , et al. Retinoic acid and interferon in human cancer: mechanistic and clinical studies . Semin Hematol 1994; 31: 31-37 .

43.

Majewski S , Szmurlo A , Marczak M , et al. Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines . Int J Cancer 1994; 57: 81-85 .

44.

Kolla V , Lindner DJ , Xiao W , et al. Modulation of interferon (IFN)-inducible gene expression by retinoic acid up-regulation of STAT1 protein in IFN-unresponsive cells . J Biol Chem 1996; 271: 10508-10514 .

45.

Matikainen S , Ronni T , Hurme M , et al. Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells . Blood 1996; 88: 114-123 .

46.

Semba RD , Muhilal, Ward BJ , et al. Abnormal T-cell subset proportions in vitamin-A-deficient children . Lancet 1993; 341: 5-8 .

47.

Alexander M , Newmark H , Miller RG. Oral beta-carotene can increase the number of OKT4 + cells in human blood . Immunol Lett 1985; 9: 221-224 .

48.

Filteau SM. Vitamin A and the acute-phase response [editorial] . Nutrition 1999; 15: 326-328 .

49.

Soprano DR , Blaner WS. Plasma retinol-binding protein. In Sporn MB , Roberst AB , Goodmam DS eds. The retinoids, Volume 2. New York: Raven Press , 1994: 275-275.

Retinol measurements and retinoid receptor gene expression in patients with multiple sclerosis

Abstract

Keywords

Get full access to this article

References